Announce Date | 08/06/2025 |
EPS Normalized Actual | $0.2 (Beat by $0.02) |
EPS GAAP Actual | $0.2 (Beat by $0.02) |
Revenue Actual | $0.48065B |
Revenue Surprise | Beat by $480.65M |
Announce Date | 10/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.07 |
EPS GAAP Estimate | $0.07 |
Revenue Estimate | $0.29665845B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 0.15 | 130.4 | 0.12854 | 0.16735 | 1 |
Dec 2028 | 0.27 | 72.44 | 0.25685 | 0.28047 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.11 | 0.046 | 0.48065B | 53.81% | 210.65M |
FQ1 2025 (Mar 2025) | 0.06 | 0.06 | 0.360062B | 40.83% | 360.06M |
FQ4 2024 (Dec 2024) | 0.0961 | 0.0961 | 0.305444B | 14.19% | 305.44M |
FQ3 2024 (Sep 2024) | 0.255 | 0.255 | 0.313476B | 37.93% | 313.48M |
FQ2 2024 (Jun 2024) | 0 | 0 | 0.222026B | 20.17% | 222.03M |
FQ1 2024 (Mar 2024) | -0.08 | -0.08 | 0.21306B | 12.09% | 213.06M |
FQ4 2023 (Dec 2023) | -0.067 | -0.067 | 0.26209B | 19.83% | 262.09M |
FQ3 2023 (Sep 2023) | -0.0592 | -0.0592 | 0.194583B | 5.96% | 194.58M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.07
Consensus Revenue Estimates
0.29665845B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.24 | -- | 0.22402 | 0.25567 | 1 |
FQ3 2027 (Sep 2027) | 0.26 | -- | 0.25275 | 0.26571 | 1 |
FQ2 2027 (Jun 2027) | 0.26 | -- | 0.25275 | 0.26571 | 1 |
FQ1 2027 (Mar 2027) | 0.28 | -- | 0.26136 | 0.29828 | 1 |
FQ4 2026 (Oct 2026) | 0.0661 | -- | 0.0661 | 0.0661 | 0 |
FQ3 2026 (Jul 2026) | 0.0683 | -- | 0.0683 | 0.0683 | 0 |
FQ2 2026 (Jun 2026) | 0.0744 | -47.85 | 0.0744 | 0.0744 | 0 |
FQ1 2026 (Mar 2026) | 0.0759 | 20.95 | 0.0759 | 0.0759 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.56B | -- | 0.53B | 0.58B | 1 |
FQ3 2027 (Sep 2027) | 0.52B | -- | 0.51B | 0.53B | 2 |
FQ2 2027 (Jun 2027) | 0.52B | -- | 0.51B | 0.53B | 2 |
FQ1 2027 (Mar 2027) | 0.56B | -- | 0.53B | 0.59B | 1 |
FQ4 2026 (Oct 2026) | 0.27B | -- | 0.27B | 0.27B | 0 |
FQ3 2026 (Jul 2026) | 0.27B | -- | 0.27B | 0.27B | 0 |
FQ2 2026 (Jun 2026) | 0.27B | -79.58 | 0.27B | 0.27B | 0 |
FQ1 2026 (Mar 2026) | 0.27B | -34.03 | 0.27B | 0.27B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.064 | 0.11 | 0.046 | 41.82% |
FQ1 2025 (Mar 2025) | 0.06 | 0.06 | 100% | |
FQ4 2024 (Dec 2024) | 0.0961 | 0.0961 | 100% | |
FQ3 2024 (Sep 2024) | 0.255 | 0.255 | 100% | |
FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
FQ1 2024 (Mar 2024) | -0.08 | -0.08 | 100% | |
FQ4 2023 (Dec 2023) | -0.067 | -0.067 | 100% | |
FQ3 2023 (Sep 2023) | -0.0592 | -0.0592 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0.27B | $0.48B | $210.65M | 43.83% |
FQ1 2025 (Mar 2025) | $0B | $0.36B | $360.06M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.31B | $305.44M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.31B | $313.48M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.22B | $222.03M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.21B | $213.06M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.26B | $262.09M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.19B | $194.58M | 100% |